Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC309

Brolucisúmab

  • Status:
    Veitt
  • Application date:
    15.7.2020
  • Application published:
    15.8.2020
  • Grant published:
    15.4.2022
  • Max expiry date:
    24.6.2034
  • Medicine name:
    Beovu
  • Medicine for children:
    No

Timeline

Today
15.7.2020Application
15.8.2020Publication
15.4.2022Registration
24.6.2034Expires

Marketing license

  • IS authorization number:
    EU/1/19/1417/001; EU/1/19/1417/002
  • Date:
    18.2.2020
  • Foreign authorization number:
    EU/1/19/1417
  • Date:
    13.2.2020

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, Basel CH

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents